Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Hip Int ; 31(4): 555-561, 2021 Jul.
Article in English | MEDLINE | ID: mdl-32028802

ABSTRACT

AIMS: One of the instruments in the orthopaedic surgeon's armamentarium to face the challenges associated with periprosthetic fracture around the stem of a hip replacement is the tapered, fluted, modular, titanium (TFMT) stem. Our aim was to study its clinical and radiological outcomes. PATIENTS AND METHODS: During the period 2010-2016 86 patients (55 females; median age 78.2 years; mean BMI 26.3 kg/m2; median ASA classification 2) underwent 87 revisions for a Vancouver B periprosthetic fracture using a Stryker Restoration Cone-Conical stem. RESULTS: After a median follow-up of 2.9 years no stem had to be revised and no case of stem fracture was found. Dislocation was the most common complication and occurred in 18% of patients. Other major complications were deep infection (n = 4), subsidence >5 mm (n = 7), and nonunion (n = 5). 3-month and 1-year mortality was 10% and 15% respectively and was strongly correlated with age, deep infection, and ASA classification. The median EQ-5D health state index at final follow-up was 0.78 and all patients were ambulatory. CONCLUSIONS: The complication most commonly encountered was dislocation and can likely be prevented by the use of large heads, adequate reduction and fixation of the trochanteric area and restoration of the native anatomy. Contrary to previous concerns, fracture and subsidence of these modular stems do not appear to be a significant problem in this geriatric population.


Subject(s)
Arthroplasty, Replacement, Hip , Femoral Fractures , Hip Prosthesis , Periprosthetic Fractures , Aged , Arthroplasty, Replacement, Hip/adverse effects , Female , Femoral Fractures/surgery , Humans , Periprosthetic Fractures/diagnostic imaging , Periprosthetic Fractures/etiology , Periprosthetic Fractures/surgery , Prosthesis Design , Reoperation , Retrospective Studies , Titanium , Treatment Outcome
2.
J Patient Saf ; 16(4): e292-e298, 2020 12.
Article in English | MEDLINE | ID: mdl-32897039

ABSTRACT

OBJECTIVE: The aim of the study was to design an objective, transparent, pragmatic, and flexible workflow to assist with patient selection during the initial phase of return to elective orthopedic surgery during the COVID-19 pandemic with the main purpose of enhancing patient safety. METHODS: A multidisciplinary working group was formed consisting of representatives for orthopedics, epidemiology, ethics, infectious diseases, cardiovascular diseases, and intensive care medicine. Preparation for upcoming meetings consisted of reading up on literature and testing of proposed methodologies on our own waiting lists. RESULTS: A workflow based on 3 domains, that is, required resources, patient fitness, and time sensitivity of the procedure, was considered most useful. All domains function as standalones, in a specific order, and no sum score is used. The domain of required resources demands input from the surgical team, results in a categorical (yes or no) outcome, and generates a list of potential patients who can be scheduled for surgery under these particular circumstances. The (weighted) items for the domain of patient fitness are the same for every patient, are scored on a numerical scale, but are likely to change during the pandemic as more data become available. Time sensitivity of the procedure is again scored on a numerical scale and becomes increasingly important when returning to elective surgery proves to be acceptably safe. After patient selection, an augmented informed consent, screening, and testing according to local guidelines will take place. CONCLUSIONS: A workflow is proposed for patient selection aiming for the safest possible return to elective orthopedic surgery during the COVID-19 pandemic.


Subject(s)
Coronavirus Infections/epidemiology , Elective Surgical Procedures/methods , Orthopedic Procedures/methods , Patient Selection , Pneumonia, Viral/epidemiology , Betacoronavirus/isolation & purification , COVID-19 , Coronavirus Infections/diagnosis , Coronavirus Infections/prevention & control , Humans , Interdisciplinary Communication , Pandemics/prevention & control , Pneumonia, Viral/diagnosis , Pneumonia, Viral/prevention & control , SARS-CoV-2
3.
PLoS One ; 14(11): e0224745, 2019.
Article in English | MEDLINE | ID: mdl-31697717

ABSTRACT

Skeletal muscle plasticity is reflected by a dynamic balance between protein synthesis and breakdown, with basal muscle tissue protein synthesis rates ranging between 0.02 and 0.09%/h. Though it is evident that other musculoskeletal tissues should also express some level of plasticity, data on protein synthesis rates of most of these tissues in vivo in humans is limited. Six otherwise healthy patients (62±3 y), scheduled to undergo unilateral total knee arthroplasty, were subjected to primed continuous intravenous infusions with L-[ring-13C6]-Phenylalanine throughout the surgical procedure. Tissue samples obtained during surgery included muscle, tendon, cruciate ligaments, cartilage, bone, menisci, fat, and synovium. Tissue-specific fractional protein synthesis rates (%/h) were assessed by measuring the incorporation of L-[ring-13C6]-Phenylalanine in tissue protein and were compared with muscle tissue protein synthesis rates using a paired t test. Tendon, bone, cartilage, Hoffa's fat pad, anterior and posterior cruciate ligament, and menisci tissue protein synthesis rates averaged 0.06±0.01, 0.03±0.01, 0.04±0.01, 0.11±0.03, 0.07±0.02, 0.04±0.01, and 0.04±0.01%/h, respectively, and did not significantly differ from skeletal muscle protein synthesis rates (0.04±0.01%/h; P>0.05). Synovium derived protein (0.13±0.03%/h) and intercondylar notch bone tissue protein synthesis rates (0.03±0.01%/h) were respectively higher and lower compared to skeletal muscle protein synthesis rates (P<0.05 and P<0.01, respectively). Basal protein synthesis rates in various musculoskeletal tissues are within the same range of skeletal muscle protein synthesis rates, with fractional muscle, tendon, bone, cartilage, ligament, menisci, fat, and synovium protein synthesis rates ranging between 0.02 and 0.13% per hour in vivo in humans. Clinical trial registration: NTR5147.


Subject(s)
Bone and Bones/metabolism , Cartilage/metabolism , Ligaments/metabolism , Muscle, Skeletal/metabolism , Protein Biosynthesis , Tendons/metabolism , Female , Humans , Male , Middle Aged , Phenylalanine/metabolism , Protein Binding
4.
Case Rep Orthop ; 2019: 1538158, 2019.
Article in English | MEDLINE | ID: mdl-31467753

ABSTRACT

BACKGROUND: Carbon-fiber-reinforced Polyetheretherketone (CFR-PEEK) nails are gaining interest as they have biomechanical properties potentially capable of overcoming disadvantages of conventional metal nails. CASE SUMMARY: Three cases are illustrated which required superior mechanical toughness, compatibility with radiotherapy, and postoperative advanced imaging. CONCLUSION: CFR-PEEK nails seem to have a niche role in distinct groups of patients.

5.
Ned Tijdschr Geneeskd ; 158: A7726, 2014.
Article in Dutch | MEDLINE | ID: mdl-24988171

ABSTRACT

We report the case of a 64-year-old fanatic female walker who presented with pain of her right distal tibia. MRI and bone scan showed a horizontal stress fracture of the distal tibia which was treated conservatively by means of cast immobilisation.


Subject(s)
Casts, Surgical , Fractures, Stress/diagnosis , Tibial Fractures/diagnosis , Ankle Joint/pathology , Female , Fractures, Stress/therapy , Humans , Middle Aged , Tibial Fractures/therapy , Treatment Outcome
6.
Ned Tijdschr Geneeskd ; 157(44): A6735, 2013.
Article in Dutch | MEDLINE | ID: mdl-24168851

ABSTRACT

A 76-year-old man visited the Emergency Room because of pain of a progressive, swelling of his right lower leg that had developed 69 years ago after a posttraumatic compartment syndrome. We performed debridement on the necrotic, infected wound and made the diagnosis 'calcific myonecrosis'.


Subject(s)
Calcinosis/diagnosis , Compartment Syndromes/complications , Debridement/methods , Necrosis/diagnosis , Aged , Calcinosis/etiology , Calcinosis/surgery , Compartment Syndromes/surgery , Humans , Leg Injuries/complications , Leg Injuries/surgery , Male , Muscle, Skeletal/pathology , Necrosis/etiology , Necrosis/surgery , Wound Healing
7.
Eur J Paediatr Neurol ; 17(6): 639-44, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23871360

ABSTRACT

BACKGROUND: Little is known about the long-term effects of Continuous intrathecal Baclofen (CITB) therapy in non-ambulant children with intractable spastic Cerebral Palsy (CP). AIM: To determine whether short-term beneficial effects of CITB therapy are present at the long-term, and whether caregivers would choose CITB therapy for their child again considering the advantages and disadvantages encountered over the years. METHODS: Long-term follow-up data were obtained of the children whom had previously participated in a RCT on CITB by the Dutch Study Group on Spasticity. Quality of life (QoL) was assessed by the Child Health Questionnaire (CHQ), current satisfaction with CITB was measured by use of a Visual Analogue Scale regarding previously set treatment goals, functioning in daily living was determined by a questionnaire concerning functioning of the child, and possible detrimental effects of CITB therapy encountered over the years were noted. All data were acquired via interview of the caregivers. RESULTS: All 17 children of the former trial participated in this study. Previously identified significant positive effects on pain (CHQ 46.8 vs. 74.38, p = 0.002; VAS 2.4 vs. 8.01, p = 0.02), ease of care (VAS 2.0 vs. 7.26, p = 0.00), and mental health (CHQ 67.2 vs. 75.94, p = 0.010) were still present at the end of the trial. Novel significant positive effects were noted at six to nine years follow-up, i.e. significantly improved scores on the Parent Impact - Emotional subscale (CHQ 66.0 vs. 78.2, p = 0.008), Parent Impact - Time subscale (CHQ 68.9 vs. 91.72, p = 0.002), and the Physical Summary (CHQ 17.6 vs. 27.4, p = 0.019) compared to baseline. Ninety-four percent of the caregivers would choose CITB treatment again for their child again. CONCLUSION: The beneficial effects of CITB are present at the long term and caregiver satisfaction is high.


Subject(s)
Baclofen/administration & dosage , Cerebral Palsy/drug therapy , Muscle Relaxants, Central/administration & dosage , Muscle Spasticity/drug therapy , Adolescent , Caregivers/psychology , Cerebral Palsy/complications , Child , Female , Humans , Injections, Spinal , Longitudinal Studies , Male , Muscle Spasticity/etiology , Muscle Spasticity/psychology , Outcome Assessment, Health Care , Quality of Life , Statistics, Nonparametric , Surveys and Questionnaires , Visual Analog Scale
9.
BMC Neurol ; 10: 52, 2010 Jun 22.
Article in English | MEDLINE | ID: mdl-20569438

ABSTRACT

BACKGROUND: Cerebral palsy (CP) may cause severe spasticity, requiring neurosurgical procedures. The most common neurosurgical procedures are continuous infusion of intrathecal baclofen and selective dorsal rhizotomy. Both are invasive and complex procedures. We hypothesized that a percutaneous radiofrequency lesion of the dorsal root ganglion (RF-DRG) could be a simple and safe alternative treatment. We undertook a pilot study to test this hypothesis. METHODS: We performed an RF-DRG procedure in 17 consecutive CP patients with severe hip flexor/adductor spasms accompanied by pain or care-giving difficulties. Six children were systematically evaluated at baseline, and 1 month and 6 months after treatment by means of the Modified Ashworth Scale (MAS), Gross Motor Function Measure (GMFM) and a self-made caregiver's questionnaire. Eleven subsequent children were evaluated using a Visual Analogue Scale (VAS) for spasticity, pain and ease of care. RESULTS: A total of 19 RF-DRG treatments were performed in 17 patients. We found a small improvement in muscle tone measured by MAS, but no effect on the GMFM scale. Despite this, the caregivers of these six treated children unanimously stated that the quality of life of their children had indeed improved after the RF-DRG. In the subsequent 11 children we found improvements in all VAS scores, in a range comparable to the conventional treatment options. CONCLUSION: RF-DRG is a promising new treatment option for severe spasticity in CP patients, and its definitive effectiveness remains to be defined in a randomised controlled trial.


Subject(s)
Cerebral Palsy/surgery , Ganglia, Spinal/surgery , Muscle Spasticity/surgery , Pain/surgery , Radiofrequency Therapy , Radiosurgery/methods , Adolescent , Caregivers , Cerebral Palsy/physiopathology , Child , Female , Follow-Up Studies , Hip , Humans , Male , Muscle Spasticity/physiopathology , Muscle Tonus , Pain/physiopathology , Pilot Projects , Quality of Life , Severity of Illness Index , Time Factors , Treatment Outcome , Young Adult
11.
Eur J Paediatr Neurol ; 12(3): 231-8, 2008 May.
Article in English | MEDLINE | ID: mdl-17933567

ABSTRACT

OBJECTIVE: This study examined the reliability and efficiacy of the Visual Analogue Scale (VAS) in evaluating spasticity treatment in an outpatient setting. PATIENTS AND METHODS: We used a parent-reported VAS device for evaluating the effects of Botulinum Toxin A (BTX-A). Data were collected on 55 children with cerebral palsy. Individual goals of treatment were formulated in close consultation with the caregivers. The categories of treatment options were improvement of pain, problems with nursing, sitting position, standing and walking. RESULTS: Seventy-four interventions were performed in 55 children. A statistically significant effect was found for improvement of nursing, standing and walking. No statistically significant effect for pain was found, probably because of small numbers. In seven children there was no effect at all. Side effects were observed in five children. CONCLUSION: In using a VAS instrument, beneficial effects were found for nursing, standing and walking after BTX-A treatment. A positive (not significant) correlation was found between the VAS and the Modified Tardieu for those children who also underwent a gait analysis. Evaluating spasticity treatment with the use of the VAS has an important advantage because it is a quick and easy method for evaluating individually defined treatment goals in an outpatient setting, in which time-consuming evaluations are not an option.


Subject(s)
Botulinum Toxins, Type A/therapeutic use , Cerebral Palsy/drug therapy , Muscle Spasticity/drug therapy , Neuromuscular Agents/therapeutic use , Pain Measurement , Adolescent , Cerebral Palsy/complications , Child , Female , Humans , Male , Muscle Spasticity/etiology , Pain/drug therapy , Sensitivity and Specificity , Treatment Outcome , Walking
SELECTION OF CITATIONS
SEARCH DETAIL
...